Rigel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
05 Feb 24 | Sell€56,015 | Raul Rodriguez | Individual | 5,289.4 | €10.63 | |
05 Feb 24 | Sell€13,367 | Dean Schorno | Individual | 1,262.8 | €10.63 | |
05 Feb 24 | Sell€15,379 | David Santos | Individual | 1,451.9 | €10.63 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 201,804 | 1.15% |
Hedge Funds | 2,470,788 | 14% |
General Public | 5,228,138 | 29.7% |
Institutions | 9,714,310 | 55.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,561,443 | €41.2m | 3.21% | no data | |||
1,536,000 | €40.6m | -5.42% | 1.0% | |||
1,460,675 | €38.6m | 2.66% | no data | |||
1,046,206 | €27.6m | 7,890% | 0.01% | |||
985,291 | €26.0m | 2.46% | no data | |||
934,788 | €24.7m | -10.4% | 1.73% | |||
441,765 | €11.7m | 0% | 0.02% | |||
421,780 | €11.1m | -23.3% | 0.03% | |||
399,663 | €10.6m | 2.27% | no data | |||
367,795 | €9.7m | 0.7% | no data | |||
309,100 | €8.2m | 1.34% | 2.68% | |||
290,000 | €7.7m | 0% | 5.81% | |||
240,968 | €6.4m | 103% | 0.01% | |||
177,340 | €4.7m | -25.6% | 0.02% | |||
160,000 | €4.2m | 0% | no data | |||
144,251 | €3.8m | 2.99% | no data | |||
141,946 | €3.7m | -2.07% | 0.01% | |||
131,163 | €3.5m | 0% | no data | |||
116,915 | €3.1m | 26.5% | 0.25% | |||
115,163 | €3.0m | 0% | no data | |||
98,006 | €2.6m | 29.7% | 0.01% | |||
94,549 | €2.5m | 5.13% | 0.05% | |||
77,407 | €2.0m | 0% | no data | |||
74,502 | €2.0m | 34.5% | 0.01% | |||
64,540 | €1.7m | 0% | 0.02% |